Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection

1Cancer in Slovenia 2015. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2018. Cancer in Slovenia 2015 Ljubljana Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia 2018Search in Google Scholar

2Cufer T, Kosnik M. [Clinical Registry of Lung Cancer Patients]. [Slovenian]. Onkologija 2013; 1: 8-10. Cufer T Kosnik M [Clinical Registry of Lung Cancer Patients] [Slovenian]. Onkologija 2013 1 8 10Search in Google Scholar

3Postmus PE, Kerr KM, Oudkerk M, Waller DA, Vansteenkiste J, Escriu C, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28(Suppl 4): 1-21. doi: 10.1093/annonc/mdx222 Postmus PE Kerr KM Oudkerk M Waller DA Vansteenkiste J Escriu C et al Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2017 28Suppl 4 1 21 10.1093/annonc/mdx22228881918Open DOISearch in Google Scholar

4Lindberg K, Nyman J, Kallskog VR, Hoyer M, Lund A, Lax I, et al. Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience. Acta Oncol 2015; 54: 1096-104. doi: 10.3109/0284186X.2015.1020966 Lindberg K Nyman J Kallskog VR Hoyer M Lund A Lax I et al Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience Acta Oncol 2015 54 1096 104 10.3109/0284186X.2015.102096625813471Open DOISearch in Google Scholar

5Verstegen NE, Lagerwaard FJ, Hashemi SM, Dahele M, Slotman BJ, Senan S. Patterns of disease recurrence after SABR for early stage non-small-cell lung cancer: optimizing follow-up schedules salvage therapy. J Thorac Oncol 2015; 10: 1195-200. doi: 10.1097/JTO.0000000000000576 Verstegen NE Lagerwaard FJ Hashemi SM Dahele M Slotman BJ Senan S Patterns of disease recurrence after SABR for early stage non-small-cell lung cancer: optimizing follow-up schedules salvage therapy J Thorac Oncol 2015 10 1195 200 10.1097/JTO.000000000000057626200274Open DOISearch in Google Scholar

6Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824. doi: 10.1164/rccm.2009-040GL Raghu G Collard HR Egan JJ Martinez FJ Behr J Brown KK et al An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 2011 183 788 824 10.1164/rccm.2009-040GL545093321471066Open DOISearch in Google Scholar

7Rudd RM, Prescott RJ, Chalmers JC, Johnston IDA; Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival. Thorax 2007; 62: 62-66. doi: 10.1136/ thx.2005.045591 Rudd RM Prescott RJ Chalmers JC Johnston IDA Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival Thorax 2007 62 62 66 10.1136/ thx.2005.045591Open DOISearch in Google Scholar

8Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J 2015; 46: 1113-30. doi: 10.1183/13993003.02316-2014 Raghu G Amatto VC Behr J Stowasser S Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review Eur Respir J 2015 46 1113 30 10.1183/13993003.02316-201426424523Open DOISearch in Google Scholar

9Omori T, Tajiri M, Baba T, Ogura T, Iwasawa T, Okudela K, et al. Pulmonary resection for lung cancer in patients with idiopathic interstitial pneumonia. Ann Thorac Surg 2015; 100: 954-60. doi: 10.1016/j.athoracsur.2015.03.094 Omori T Tajiri M Baba T Ogura T Iwasawa T Okudela K et al Pulmonary resection for lung cancer in patients with idiopathic interstitial pneumonia Ann Thorac Surg 2015 100 954 60 10.1016/j.athoracsur.2015.03.09426116477Open DOISearch in Google Scholar

10Saito Y, Kawai Y, Takahashi N, Ikeya T, Murai K, Kawabata Y, et al. Survival after surgery for pathologic stage IA non-small-cell lung cancer associated with idiopathic pulmonary fibrosis. Ann Thorac Surg 2011; 92: 1812-7. doi: 10.1016/j.athoracsur.2011.06.055 Saito Y Kawai Y Takahashi N Ikeya T Murai K Kawabata Y et al Survival after surgery for pathologic stage IA non-small-cell lung cancer associated with idiopathic pulmonary fibrosis Ann Thorac Surg 2011 92 1812 7 10.1016/j.athoracsur.2011.06.05521944440Open DOISearch in Google Scholar

11Lee T, Park JY, Lee HY, Cho YJ, Yoon HI, Lee JH, et al. Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival. Respir Med 2014; 108: 1549-55. doi: 10.1016/j.rmed.2014.07.020 Lee T Park JY Lee HY Cho YJ Yoon HI Lee JH et al Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival Respir Med 2014 108 1549 55 10.1016/j.rmed.2014.07.02025175479Open DOISearch in Google Scholar

12Ghatol A, Ruhl AP, Danoff SK. Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature. Lung 2012; 190: 373-80. doi: 10.1007/ s00408-012-9389-5 Ghatol A Ruhl AP Danoff SK Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature Lung 2012 190 373 80 10.1007/ s00408-012-9389-5Open DOISearch in Google Scholar

13Ueki N, Matsuo Y, Togashi Y, Kubo T, Shibuya K, Iizuka Y, et al. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol 2015: 10: 116-25. doi: 10.1097/JTO.0000000000000359 Ueki N Matsuo Y Togashi Y Kubo T Shibuya K Iizuka Y et al Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer J Thorac Oncol 2015 10 116 25 10.1097/JTO.000000000000035925376512Open DOISearch in Google Scholar

14Isobe K, Hata Y, Sakamoto S, Takai y, Shibuya K, Homma S. Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy. Respirology 2010; 15: 88-92. doi: 10.1111/j.1440-1843.2009.01666.x Isobe K Hata Y Sakamoto S Takai y Shibuya K Homma S Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy Respirology 2010 15 88 92 10.1111/j.1440-1843.2009.01666.x19947998Open DOISearch in Google Scholar

15Yamaguchi S, Ohguri T, Ide S, Aoki T, Imada H, Yahara K, et al. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. Lung Cancer 2013; 82: 260-5. doi: 10.1016/j.lungcan.2013.08.024 Yamaguchi S Ohguri T Ide S Aoki T Imada H Yahara K et al Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis Lung Cancer 2013 82 260 5 10.1016/j.lungcan.2013.08.02424054547Open DOISearch in Google Scholar

16Takeda A, Sanuki N, Enomoto T, Kunieda E. Subclinical interstitial lung disease: is it a risk factor for fatal radiation pneumonitis following stereotactic body radiotherapy? Lung Cancer 2014; 83: 112. doi: 10.1016/j. lungcan.2013.10.009 Takeda A Sanuki N Enomoto T Kunieda E Subclinical interstitial lung disease: is it a risk factor for fatal radiation pneumonitis following stereotactic body radiotherapy? Lung Cancer 2014 83 112 10.1016/j. lungcan.2013.10.009Open DOISearch in Google Scholar

17Goto T, Maeshima A, Oyamada Y, Kato R. Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cáncer. Int J Clin Oncol 2014; 19: 266-73. doi: 10.1007/s10147-013-0566-1 Goto T Maeshima A Oyamada Y Kato R Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cáncer Int J Clin Oncol 2014 19 266 73 10.1007/s10147-013-0566-123660786Open DOISearch in Google Scholar

18Kawasaki H, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2002; 81: 33-7. doi: 10.1002/jso.10145 Kawasaki H Nagai K Yoshida J Nishimura M Nishiwaki Y Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis J Surg Oncol 2002 81 33 7 10.1002/jso.1014512210025Open DOISearch in Google Scholar

19Naccche J, Gibiot Q, Monnet I, Antoine M, Wislez M, Chouaid C, et al. Lung cancer and interstitial lung disease: a literature review. J Thorac Dis 2018; 10: 3829-44. doi: 10.21037/jtd.2018.05.75 Naccche J Gibiot Q Monnet I Antoine M Wislez M Chouaid C et al Lung cancer and interstitial lung disease: a literature review J Thorac Dis 2018 10 3829 44 10.21037/jtd.2018.05.75605186730069384Open DOISearch in Google Scholar

20Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, Maher MM, et al. Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung 2015; 193: 71-7. doi: 10.1007/s00408-014-9664-8 Khan KA Kennedy MP Moore E Crush L Prendeville S Maher MM et al Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis Lung 2015 193 71 7 10.1007/s00408-014-9664-825381634Open DOISearch in Google Scholar

21Watanabe A, Miyajima M, Mishina T, Nakazawa J, Harada R, Kawaharada N, et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis. Gen Thorac Cardiovasc Surg 2013; 61: 254-61. doi: 10.1007/s11748-012-0180-6 Watanabe A Miyajima M Mishina T Nakazawa J Harada R Kawaharada N et al Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis Gen Thorac Cardiovasc Surg 2013 61 254 61 10.1007/s11748-012-0180-623188513Open DOISearch in Google Scholar

22Watanabe A, Higami T, Ohori S, Koyanagi T, Nakashima S. Mawatari T. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 2008; 136: 1357-63. doi: 10.1016/j. jtcvs.2008.07.016 Watanabe A Higami T Ohori S Koyanagi T Nakashima S Mawatari T Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 2008 136 1357 63 10.1016/j. jtcvs.2008.07.016Open DOISearch in Google Scholar

23Fujimoto T, Okazaki T, Matsukura T, Hanawana T, Yamashita N, Nishimura K, et al. Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surgery 2003; 76: 1674-9. doi: 10.1016/S0003-4975(03)00966-4 Fujimoto T Okazaki T Matsukura T Hanawana T Yamashita N Nishimura K et al Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surgery 2003 76 1674 9 10.1016/S0003-4975(03)00966-414602310Open DOISearch in Google Scholar

24Martinez FJ, Chisholm A, Collard HR, Flaherty KR, Myers J, Raghu G, et al. The diagnosis of idiopathic pulmonary fibrosis: current and future approaches. Lancet Respir Med 2017; 5: 61-71. doi: 10.1016/S2213-2600(16)30325-3 Martinez FJ Chisholm A Collard HR Flaherty KR Myers J Raghu G et al The diagnosis of idiopathic pulmonary fibrosis: current and future approaches Lancet Respir Med 2017 5 61 71 10.1016/S2213-2600(16)30325-3552414827932290Open DOISearch in Google Scholar